Brooks Automation, Inc.
BRKS
Rang in Aktien
#2427
Brooks Automation, Inc. (BRKS), founded in 1978 and headquartered in... Brooks Automation, Inc. (BRKS), founded in 1978 and headquartered in Chelmsford, Massachusetts, stands as a global leader in delivering advanced automation and cryogenic technologies to clients in approximately 50 countries. The company operates through two distinct divisions: the Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group is dedicated to the semiconductor capital equipment sector, offering sophisticated wafer automation and contamination control solutions alongside a full suite of support services. This segment's product range encompasses a variety of atmospheric and vacuum robots, robotic modules, and comprehensive tool automation systems, all designed to ensure precise handling and maintain pristine conditions within wafer environments. They also provide automated cleaning and inspection systems for wafer carriers, reticle pod cleaners, and stockers. Beyond products, this group offers crucial services including repairs, diagnostics, installations, spare parts, and productivity-boosting upgrades. The Brooks Life Science Systems division caters to the intricate demands of the life sciences sample management market. It supplies automated cold storage systems and an extensive array of consumables, such as various formats of racks, tubes, caps, plates, and foils. Additionally, the segment manufactures specialized instruments for laboratory tasks like labeling, bar coding, capping, de-capping, auditing, sealing, peeling, and piercing tubes and plates. Its comprehensive service offerings span complete sample management, including both on-site and off-site storage, meticulous cold chain logistics, secure sample transport and relocation, bio-processing solutions, disaster recovery, and business continuity planning, complemented by expert project management and consulting. This division further develops advanced sample intelligence software, facilitates customer technology integration, and provides solutions for optimizing laboratory workflow scheduling, managing sample inventory and logistics, monitoring environmental conditions, overseeing clinical trials and consent, as well as offering planning, data management, virtualization, and visualization services. Moreover, it delivers gene sequencing analysis and synthesis capabilities.
Aktienkurs
$113.10
Zuletzt synchronisiert: 2021-11-30
Marktkapitalisierung
$7.94B
Veränderung (1 Tag)
-2.73%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Brooks Automation, Inc. (BRKS)
Kategorie
Technology
KGV für Brooks Automation, Inc. (BRKS)
KGV zum October 2026 TTM: -18.42
Laut den neuesten Finanzberichten und dem Aktienkurs von Brooks Automation, Inc. beträgt das aktuelle P/E-Verhältnis (TTM) -18.42. Am Ende des Jahres 2024 hatte das Unternehmen ein P/E von -15.62.
P/E-Verlaufsdaten für Brooks Automation, Inc. von 2001 bis 2026
P/E-Verhältnis am Ende jedes Jahres
| Jahr | KGV | ändert |
|---|---|---|
| 2026 (TTM) | -18.42 | -21.75% |
| 2025 | -23.54 | 50.70% |
| 2024 | -15.62 | -93.30% |
| 2023 | -233.24 | 3,016.70% |
| 2022 | -7.48 | -110.91% |
| 2021 | 68.60 | 30.75% |
| 2020 | 52.47 | -43.29% |
| 2019 | 92.51 | 343.86% |
| 2018 | 20.84 | -38.22% |
| 2017 | 33.74 | -351.90% |
| 2016 | -13.39 | -124.13% |
| 2015 | 55.51 | -64.65% |
| 2014 | 157.02 | -157.24% |
| 2013 | -274.31 | -7,486.53% |
| 2012 | 3.71 | -9.39% |
| 2011 | 4.10 | -43.51% |
| 2010 | 7.26 | -439.96% |
| 2009 | -2.13 | -6.41% |
| 2008 | -2.28 | -114.17% |
| 2007 | 16.10 | -55.78% |
| 2006 | 36.40 | -149.21% |
| 2005 | -73.96 | -430.53% |
| 2004 | 22.38 | -640.81% |
| 2003 | -4.14 | 908.16% |
| 2002 | -0.41 | -97.32% |
| 2001 | -15.32 | 0.00% |
P/E-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/E Ratio | P/E Ratio-Differenz | Land |
|---|---|---|---|
| 27.84 | -251.12% |
US
|
|
| 24.27 | -231.77% |
TW
|
|
| 41.91 | -327.53% |
US
|
|
| 12.14 | -165.90% |
US
|
|
| 140.28 | -861.58% |
US
|
Wie liest man ein P/E Ratio?
Das Kurs-Gewinn-Verhältnis (P/E Ratio) misst das Verhältnis zwischen dem Aktienkurs eines Unternehmens und seinem Gewinn pro Aktie.
Ein niedriges, aber positives P/E weist auf ein Unternehmen hin, das hohe Gewinne im Verhältnis zur aktuellen Bewertung erzielt und möglicherweise unterbewertet ist. Ein Unternehmen mit einem hohen negativen (nahe 0) P/E macht hohe Verluste im Verhältnis zur Bewertung.
Unternehmen mit einem P/E über 30 oder negativ werden allgemein als "Wachstumsaktien" betrachtet, was bedeutet, dass Investoren erwarten, dass das Unternehmen in Zukunft wächst oder profitabel wird.
Unternehmen mit einem positiven P/E unter 10 gelten im Allgemeinen als "Value-Aktien", was bedeutet, dass das Unternehmen bereits sehr profitabel ist, aber in Zukunft wahrscheinlich kein starkes Wachstum aufweisen wird.